Integrative proteomic analyses across common cardiac diseases yield mechanistic insights and enhanced prediction
Open accessPublished version of a preprint
The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Abstract
Cardiac diseases represent common highly morbid conditions for which molecular mechanisms remain incompletely understood. Here we report the analysis of 1,459 protein measurements in 44,313 UK Biobank participants to characterize the circulating proteome associated with incident coronary artery disease, heart failure, atrial fibrillation and aortic stenosis. Multivariable-adjusted Cox regression identified 820 protein–disease associations—including 441 proteins—at Bonferroni-adjusted P < 8.6 × 10−6. Cis-Mendelian randomization suggested causal roles aligning with epidemiological findings for 4% of proteins identified in primary analyses, prioritizing therapeutic targets across cardiac diseases (for example, spondin-1 for atrial fibrillation and the Kunitz-type protease inhibitor 1 for coronary artery disease). Interaction analyses identified seven protein–disease associations that differed Bonferroni-significantly by sex. Models incorporating proteomic data (versus clinical risk factors alone) improved prediction for coronary artery disease, heart failure and atrial fibrillation. These results lay a foundation for future investigations to uncover disease mechanisms and assess the utility of protein-based prevention strategies for cardiac diseases. Schuermans et al. identify a causal relationship between the circulating proteins spondin-1 and atrial fibrillation and SPINT1 and coronary artery disease and show that adding proteomic data improves clinical risk factor-based cardiovascular risk prediction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









![Extended Data Fig. 5 Correlation between the effect sizes of protein–disease associations in male vs. female participants. The scatter plots depict the correlation between the protein–disease associations’ effect sizes (that is, log[HR]) in female vs. male participants. HR indicates hazard ratio. All estimates were calculated using multivariable-adjusted Cox proportional hazards models, adjusted for age, age², self-reported race/ethnicity, the first ten principal components of genetic ancestry, smoking, normalized Townsend deprivation index, body mass index, systolic blood pressure, antihypertensive medication use, total cholesterol, high-density lipoprotein cholesterol, cholesterol-lowering medication use, serum creatinine, and prevalent type 2 diabetes. In addition, we included the cardiac outcomes that were not tested (for example, heart failure, atrial fibrillation, and aortic stenosis for incident coronary artery disease models) as time-varying covariates. The labeled protein–disease represent proteins that were associated with the indicated outcome at two-sided P < 0.05/5,836 (that is, Bonferroni-adjusted) in one sex without nominal significance (two-sided unadjusted P > 0.05) in the other sex. In addition, all proteins indicated in color had suggestive evidence for interaction by sex (two-sided unadjusted Pinteraction < 0.05). HR indicates hazard ratio. Source data](https://figures.cochat.ai/paper-figures/fb51eff2bf354293be84ffdd72d8f1bf/integrative-proteomic-analyses-across-common-cardiac-diseases-yield-mechanistic-figure-10.jpg)


![Extended Data Fig. 8 Risk (A–C) stratification and (D) prediction of incident coronary artery disease, heart failure, atrial fibrillation, and aortic stenosis by protein-based risk scores in the WHI-LLS. The indicated plots depict (A) the distributions of protein-based risk scores in cases and controls; (B) the cumulative incidence of each outcome (calculated using the Kaplan–Meier method) by protein-based score quintiles; (C) incidence rate estimates according to protein-based score deciles on a logarithmically scaled Y axis; and (D) the accuracies of the clinical, proteomic, and combined risk scores in predicting the indicated outcomes (quantified using the area under the receiver-operating characteristic curve [AUC] with corresponding 95% confidence intervals [CIs]). For (A), the vertical lines indicate the protein-based risk score values corresponding to a false positive rate (FPR) of 5.0%; the detection rates (DRs) indicate the “exact” detection rates, calculated as the unadjusted proportions of cases with a positive test result at the corresponding protein-based risk score threshold. For (C), incidence rate estimates are not displayed if the incidence of the indicated outcome in a protein score percentile bin was zero. All analyses were performed in the Women’s Health Initiative Long Life Study (WHI-LLS; n = 1,083). During a median (interquartile range) follow-up of 8.3 (5.6-8.9) years, 85 participants in the WHI-LLS cohort experienced coronary artery disease events, 100 experienced heart failure, and 182 atrial fibrillation. Source data](https://figures.cochat.ai/paper-figures/a2ea54f7bc8943708e4193b1f6812085/integrative-proteomic-analyses-across-common-cardiac-diseases-yield-mechanistic-figure-13.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Out of the 21 proteins identified in this study, we observed consistent associations for 13 proteins including GDF15, NT-proBNP, HAVCR1, TNFRSF9, IGFBP4, IL2RA, LTBP2, TNFRSF10A, PLAUR, IGFBP7, SPINK1, CD274, EDA2R 25 .”
From Connecting proteomics and genomics to identify causal biomarkers specific for aortic valve stenosis (2025) · cites this paper as [25]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089 · cited 1×
“All cis -pQTLs with P 5 × 10 −6 were clumped into largely independent loci (linkage disequilibrium R 2 0.1) using PLINK 52 .”
InfluentialRegularization Paths for Generalized Linear Models via Coordinate Descent
Friedman, J., Hastie, T., & Tibshirani, R. (2010) · Journal of Statistical Software · doi:10.18637/jss.v033.i01 · Cited by 19,927
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358
A global reference for human genetic variation
The 1000 Genomes Project Consortium, authors, C., Auton, A., Abecasis, G. R., Steering committee, Altshuler, D. M., Durbin, R. M., Abecasis, G. R., Bentley, D. R., Chakravarti, A., et al. (2015) · Nature · doi:10.1038/nature15393 · Cited by 18,247 · cited 1×
“Linkage disequilibrium information was obtained from the European panel of phase 3 of the 1000 Genomes Project 53 .”
Tissue-based map of the human proteome
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286
ggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
pROC: an open-source package for R and S+ to analyze and compare ROC curves
Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J.-C., & Müller, M. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-77 · Cited by 13,697
Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
Kuleshov, M. V., Jones, M. R., Rouillard, A. D., Fernandez, N. F., Duan, Q., Wang, Z., Koplev, S., Jenkins, S. L., Jagodnik, K. M., Lachmann, A., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw377 · Cited by 10,799 · cited 3×
“To gain insights into biological pathways associated with the identified proteins, we carried the 820 observed protein–disease associations forward for pathway enrichment analysis using the Gene Ontology resource 16 via Enrichr 17 .”
The UK Biobank resource with deep phenotyping and genomic data
Bycroft, C., Freeman, C., Petkova, D., Band, G., Elliott, L. T., Sharp, K., Motyer, A., Vukcevic, D., Delaneau, O., O’Connell, J., et al. (2018) · Nature · doi:10.1038/s41586-018-0579-z · Cited by 8,876 · cited 2×
“Anthropometric data, physical measurements and blood samples were obtained by trained study staff 42 .”
The MR-Base platform supports systematic causal inference across the human phenome
Hemani, G., Zheng, J., Elsworth, B., Wade, K. H., Haberland, V., Baird, D., Laurin, C., Burgess, S., Bowden, J., Langdon, R., et al. (2018) · eLife · doi:10.7554/elife.34408 · Cited by 7,959 · cited 1×
“MR analyses were performed using the TwoSampleMR and MendelianRandomiza-tion packages in R 58,59 .”
Giambartolomei, C., Vukcevic, D., Schadt, E. E., Franke, L., Hingorani, A. D., Wallace, C., & Plagnol, V. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004383 · Cited by 4,261
The Gene Ontology resource: enriching a GOld mine
The Gene Ontology Consortium, Carbon, S., Douglass, E., Good, B. M., Unni, D. R., Harris, N. L., Mungall, C. J., Basu, S., Chisholm, R. L., Dodson, R. J., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1113 · Cited by 3,555 · cited 2×
“To gain insights into biological pathways associated with the identified proteins, we carried the 820 observed protein–disease associations forward for pathway enrichment analysis using the Gene Ontology resource 16 via Enrichr 17 .”
Design of the Women’s Health Initiative Clinical Trial and Observational Study
(1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00078-0 · Cited by 2,585
D’Hulst, G., Soro-Arnaiz, I., Masschelein, E., Veys, K., Fitzgerald, G., Smeuninx, B., Kim, S., Deldicque, L., Blaauw, B., Carmeliet, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13889-6 · Cited by 2,310
Genomic atlas of the human plasma proteome
Sun, B. B., Maranville, J. C., Peters, J. E., Stacey, D., Staley, J. R., Blackshaw, J., Burgess, S., Jiang, T., Paige, E., Surendran, P., et al. (2018) · Nature · doi:10.1038/s41586-018-0175-2 · Cited by 2,268
The Global Burden of Cardiovascular Diseases and Risk
Vaduganathan, M., Mensah, G. A., Turco, J. V., Fuster, V., & Roth, G. A. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.11.005 · Cited by 2,217
Yavorska, O. O., & Burgess, S. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyx034 · Cited by 2,052
Plasma proteomic associations with genetics and health in the UK Biobank
Sun, B. B., Chiou, J., Traylor, M., Benner, C., Hsu, Y.-H., Richardson, T. G., Surendran, P., Mahajan, A., Robins, C., Vasquez-Grinnell, S. G., et al. (2023) · Nature · doi:10.1038/s41586-023-06592-6 · Cited by 1,880 · cited 5×
“We obtained pQTL data from 35,571 UKB-PPP participants who had their circulating proteomes profiled using the Olink Explore 1536 platform 14 .”
InfluentialPerineuronal nets stabilize the grid cell network
Christensen, A. C., Lensjø, K. K., Lepperød, M. E., Dragly, S.-A., Sutterud, H., Blackstad, J. S., Fyhn, M., & Hafting, T. (2021) · Nature Communications · doi:10.1038/s41467-020-20241-w · Cited by 1,865
Genetic regulation of the human plasma proteome in 54,306 UK Biobank participants
Sun, B. B., Chiou, J., Traylor, M., Benner, C., Hsu, Y.-H., Richardson, T. G., Surendran, P., Mahajan, A., Robins, C., Vasquez-Grinnell, S. G., et al. (2022) · doi:10.1101/2022.06.17.496443 · Cited by 1,833
Bozkurt, B., Coats, A. J. S., Tsutsui, H., Abdelhamid, C. M., Adamopoulos, S., Albert, N., Anker, S. D., Atherton, J., Böhm, M., Butler, J., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2115 · Cited by 1,665 · cited 1×
“For example, in addition to confirming the established association of natriuretic peptide elevation with so-called ‘pre-heart failure’ 35 , ROC analyses revealed that NT-proBNP was a better predictor of atrial fibrillation than all other proteins together (except NPPB or BNP).”
Self-citationBias due to participant overlap in two‐sample Mendelian randomization
Burgess, S., Davies, N. M., & Thompson, S. G. (2016) · Genetic Epidemiology · doi:10.1002/gepi.21998 · Cited by 1,624 · cited 1×
“Genetic association data were obtained from FinnGen rather than larger meta-GWASs (which often included the UKB) to avoid sample overlap between the exposure and outcome cohorts, which increases the risk of weak instrument bias in two-sample MR leading to inflated type I error rates 51 .”
Harnessing protein folding neural networks for peptide–protein docking
Tsaban, T., Varga, J. K., Avraham, O., Ben-Aharon, Z., Khramushin, A., & Schueler-Furman, O. (2022) · Nature Communications · doi:10.1038/s41467-021-27838-9 · Cited by 1,205
Burgess, S., Dudbridge, F., & Thompson, S. G. (2016) · Statistics in Medicine · doi:10.1002/sim.6835 · Cited by 1,153 · cited 1×
“We adjusted for between-variant correlation structure in all IVW models to avoid inflated estimates caused by residual correlation 55,56 .”
The druggable genome and support for target identification and validation in drug development
Finan, C., Gaulton, A., Kruger, F. A., Lumbers, R. T., Shah, T., Engmann, J., Galver, L., Kelley, R., Karlsson, A., Santos, R., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aag1166 · Cited by 1,026 · cited 4×
“%) robustly and directionally consistent protein–disease associations (Supplementary Table 14) 22 .”
InfluentialUniversal Definition and Classification of Heart Failure
Bozkurt, B., Coats, A. J., Tsutsui, H., Abdelhamid, M., Adamopoulos, S., Albert, N., Anker, S. D., Atherton, J., Böhm, M., Butler, J., et al. (2021) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2021.01.022 · Cited by 995
Self-citationAragam, K. G., Jiang, T., Goel, A., Kanoni, S., Wolford, B. N., Atri, D. S., Weeks, E. M., Wang, M., Hindy, G., Zhou, W., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01233-6 · Cited by 723
Self-citationGenomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals
Folkersen, L., Gustafsson, S., Wang, Q., Hansen, D. H., Hedman, Å. K., Schork, A., Page, K., Zhernakova, D. V., Wu, Y., Peters, J., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00287-2 · Cited by 705 · cited 1×
“Furthermore, targeted analyses of specific biomarkers suggest that integrating proteomic and genetic data can nominate causal protein–disease associations and reveal actionable drug targets in the bloodstream 12,13 .”
Self-citationOutcomes ascertainment and adjudication methods in the women's health initiative
Curb, J. D., Mctiernan, A., Heckbert, S. R., Kooperberg, C., Stanford, J., Nevitt, M., Johnson, K. C., Proulx-Burns, L., Pastore, L., Criqui, M., et al. (2003) · Annals of Epidemiology · doi:10.1016/s1047-2797(03)00048-6 · Cited by 698 · cited 1×
“…follow-up for coronary artery disease (defined as a composite of fatal and nonfatal myocardial infarction using a standardized adjudication process 64 ), heart failure (defined as probable or definite congestive heart failure hospitalization using a standardized adjudication process 65 ) and…”
Self-citationGenetic drug target validation using Mendelian randomisation
Schmidt, A. F., Finan, C., Gordillo-Marañón, M., Asselbergs, F. W., Freitag, D. F., Patel, R. S., Tyl, B., Chopade, S., Faraway, R., Zwierzyna, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16969-0 · Cited by 567 · cited 3×
“This study utilized a robust cis -MR framework (facilitating the adherence to these assumptions 20,21 ) and tested the robustness of the genetic associations through many sensitivity analyses.”
Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease
Wollert, K. C., Kempf, T., & Wallentin, L. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2016.255174 · Cited by 559 · cited 2×
“Similarly, GDF15—another pleiotropic protein expressed across multiple organ systems 31 —was the strongest bio-marker for coronary artery disease.”
Plasma protein patterns as comprehensive indicators of health
Williams, S. A., Kivimaki, M., Langenberg, C., Hingorani, A. D., Casas, J. P., Bouchard, C., Jonasson, C., Sarzynski, M. A., Shipley, M. J., Alexander, L., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0665-2 · Cited by 506
Association of Premature Natural and Surgical Menopause With Incident Cardiovascular Disease
Honigberg, M. C., Zekavat, S. M., Aragam, K., Finneran, P., Klarin, D., Bhatt, D. L., Januzzi, J. L., Scott, N. S., & Natarajan, P. (2019) · JAMA · doi:10.1001/jama.2019.19191 · Cited by 465
Self-citationFruchart, J.-C., Sacks, F., Hermans, M. P., Assmann, G., Brown, W. V., Ceska, R., Chapman, M. J., Dodson, P. M., Fioretto, P., Ginsberg, H. N., et al. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.10.002 · Cited by 463
Comprehensive analysis of HE4 expression in normal and malignant human tissues
Galgano, M. T., Hampton, G. M., & Frierson, H. F. (2006) · Modern Pathology · doi:10.1038/modpathol.3800612 · Cited by 437 · cited 1×
“As WFDC2 is expressed exclusively in noncardiovascular tissues such as the respiratory tract, male and female genitourinary system and kidneys 30 , it is likely that the strong associations of WFDC2 with cardiac outcomes stem from peripheral organ responses rather than indicating direct cardiac…”
Selecting instruments for Mendelian randomization in the wake of genome-wide association studies.
Swerdlow, D. I., Kuchenbaecker, K. B., Shah, S., Sofat, R., Holmes, M. V., White, J., Mindell, J. S., Kivimaki, M., Brunner, E. J., Whittaker, J. C., et al. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw088 · Cited by 387 · cited 4×
“This study utilized a robust cis -MR framework (facilitating the adherence to these assumptions 20,21 ) and tested the robustness of the genetic associations through many sensitivity analyses.”
InfluentialGanz, P., Heidecker, B., Hveem, K., Jonasson, C., Kato, S., Segal, M. R., Sterling, D. G., & Williams, S. A. (2016) · JAMA · doi:10.1001/jama.2016.5951 · Cited by 364
Tcheandjieu, C., Zhu, X., Hilliard, A. T., Clarke, S. L., Napolioni, V., Ma, S., Lee, K. M., Fang, H., Chen, F., Lu, Y., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01891-3 · Cited by 362
Self-citationPCSK9 inhibitors: clinical evidence and implementation
Sabatine, M. S. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0107-8 · Cited by 338 · cited 2×
“Top biological functions, molecular pathways, and cellular components were queried using the Gene Ontology resource 22,23 via Enrichr 24 .”
Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus
Ostendorf, L., Burns, M., Durek, P., Heinz, G. A., Heinrich, F., Garantziotis, P., Enghard, P., Richter, U., Biesen, R., Schneider, U., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2023325 · Cited by 329 · cited 1×
“Previous research suggests that CD38 is causally implicated in autoimmune diseases such as rheumatoid Article https://doi.org/10.1038/s44161-024-00567-0 arthritis and systemic lupus erythematosus 38,39 .”
InfluentialPatton, K. K., Ellinor, P. T., Heckbert, S. R., Christenson, R. H., DeFilippi, C., Gottdiener, J. S., & Kronmal, R. A. (2009) · Circulation · doi:10.1161/circulationaha.109.873265 · Cited by 310
Figtree, G. A., Vernon, S. T., Hadziosmanovic, N., Sundström, J., Alfredsson, J., Arnott, C., Delatour, V., Leósdóttir, M., & Hagström, E. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00272-5 · Cited by 305 · cited 1×
“For instance, most high-risk individuals remain undetected until experiencing their first clinical event 3,4 , and even under currently optimal treatment conditions, there remains substantial residual risk that is incompletely captured by traditional risk factors 5,6 .”
Simard, L., Côté, N., Dagenais, F., Mathieu, P., Couture, C., Trahan, S., Bossé, Y., Mohammadi, S., Pagé, S., Joubert, P., et al. (2017) · Circulation Research · doi:10.1161/circresaha.116.309306 · Cited by 294 · cited 1×
“Previous histological work in aortic stenosis patients revealed distinct tissue composition differences between men and women, with women showing less valvular calcification but more fibrosis than men 41 .”
Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis
LeBleu, V. S., Teng, Y., O'Connell, J. T., Charytan, D., Müller, G. A., Müller, C. A., Sugimoto, H., & Kalluri, R. (2013) · Nature Medicine · doi:10.1038/nm.2989 · Cited by 260 · cited 1×
“WFDC2 (also known as HE4)—a profibrotic protease inhibitor with a potential role in natural immunity 15 —emerged as the strongest proteomic predictor of heart failure.”
Natriuretic Peptide Testing in Heart Failure
Kim, H.-N., & Januzzi, J. L. (2011) · Circulation · doi:10.1161/circulationaha.110.979500 · Cited by 252 · cited 1×
“We also excluded NPPB from the latter set of protein-based risk scores as NPPB and NT-proBNP are encoded by the same gene and released in the circulation in equimolar quantities 25 .”
Self-citationThe Index of Multiple Deprivation 2000 and accessibility effects on health
Jordan, H., Roderick, P., & Martin, D. (2004) · Journal of Epidemiology and Community Health · doi:10.1136/jech.2003.013011 · Cited by 228 · cited 1×
“The Townsend deprivation index—an area-level score that incorporates data on home ownership, automobile ownership, employment and household over-crowding—was used as a composite measure of material deprivation 46 .”
Ho, A., & Südhof, T. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308655100 · Cited by 224 · cited 1×
“SPON1 is an extracellular protein expressed in tissues such as the heart and brain that has been implicated in Alzheimer’s dementia through its role in amyloid-β precursor protein processing 27 .”
Severino, V, Alessio, N., Farina, A., Sandomenico, A., Cipollaro, M., Peluso, G., Galderisi, U., & Chambery, A. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.445 · Cited by 214
Burgess, S., Zuber, V., Valdes‐Marquez, E., Sun, B. B., & Hopewell, J. C. (2017) · Genetic Epidemiology · doi:10.1002/gepi.22077 · Cited by 202 · cited 1×
“We adjusted for between-variant correlation structure in all IVW models to avoid inflated estimates caused by residual correlation 55,56 .”
Therapeutic Targets for Heart Failure Identified Using Proteomics and Mendelian Randomization
Henry, A., Gordillo-Marañón, M., Finan, C., Schmidt, A. F., Ferreira, J. P., Karra, R., Sundström, J., Lind, L., Ärnlöv, J., Zannad, F., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.056663 · Cited by 179 · cited 5×
“Depending on the number of cis -pQTLs included in a protein’s genetic instrument, we used different MR methods to infer causal effects 13 .”
InfluentialProteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction
Nurmohamed, N. S., Kraaijenhof, J. M., Mayr, M., Nicholls, S. J., Köenig, W., Catapano, A. L., & Stroes, E. S. G. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad161 · Cited by 172 · cited 1×
“For instance, most high-risk individuals remain undetected until experiencing their first clinical event 3,4 , and even under currently optimal treatment conditions, there remains substantial residual risk that is incompletely captured by traditional risk factors 5,6 .”
Sex Differences in Circulating Biomarkers of Cardiovascular Disease
Lau, E. S., Paniagua, S. M., Guseh, J. S., Bhambhani, V., Zanni, M. V., Courchesne, P., Lyass, A., Larson, M. G., Levy, D., & Ho, J. E. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.06.077 · Cited by 158 · cited 4×
“To gain insights into biological pathways associated with the identified proteins, we carried the 820 observed protein–disease associations forward for pathway enrichment analysis using the Gene Ontology resource 16 via Enrichr 17 .”
InfluentialStatistical methods for cis‐Mendelian randomization with two‐sample summary‐level data
Gkatzionis, A., Burgess, S., & Newcombe, P. J. (2023) · Genetic Epidemiology · doi:10.1002/gepi.22506 · Cited by 155 · cited 1×
“Because it is routinely recommended to evaluate the robustness of cis -MR estimates using multiple sensitivity analyses 57 , we performed additional analyses using different MR approaches and instrument selection parameters.”
Targeted proteomics improves cardiovascular risk prediction in secondary prevention
Nurmohamed, N. S., Belo Pereira, J. P., Hoogeveen, R. M., Kroon, J., Kraaijenhof, J. M., Waissi, F., Timmerman, N., Bom, M. J., Hoefer, I. E., Knaapen, P., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac055 · Cited by 144 · cited 1×
“For instance, smaller studies have demonstrated that sparse protein-based risk scores can improve the prediction of cardiovascular events in certain populations 7–11 .”
Blood protein assessment of leading incident diseases and mortality in the UK Biobank
Gadd, D. A., Hillary, R. F., Kuncheva, Z., Mangelis, T., Cheng, Y., Dissanayake, M., Admanit, R., Gagnon, J., Lin, T., Ferber, K. L., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00655-7 · Cited by 142 · cited 3×
“For each assay and each sample, normalized protein expression values are calculated as the log 2 -transformed ratio of sequence read counts to the counts of the extension control, corrected for plate and batch effects 14,43 .”
InfluentialNext generation plasma proteome profiling to monitor health and disease
Zhong, W., Edfors, F., Gummesson, A., Bergström, G., Fagerberg, L., & Uhlén, M. (2021) · Nature Communications · doi:10.1038/s41467-021-22767-z · Cited by 140 · cited 1×
“…participants underwent proteomic profiling using the Olink Explore 1536 platform (Olink Proteomics), which measures 1,472 protein analytes across four different panels (the Cardiometabolic, Inflammation, Neurology and Oncology panels) representing 1,463 unique proteins (Supplementary Table 1) 44 .”
Cole, S., Walsh, A. M., Yin, X., Wechalekar, M. D., Smith, M., Proudman, S., Veale, D. J., Fearon, U., Pitzalis, C., Humby, F., et al. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1578-z · Cited by 139 · cited 2×
“CD38 is a glycoprotein expressed across various immune cells including lymphocytes and plasma cells 38 .”
InfluentialMiyazawa, K., Ito, K., Ito, M., Zou, Z., Kubota, M., Nomura, S., Matsunaga, H., Koyama, S., Ieki, H., Akiyama, M., et al. (2023) · Nature Genetics · doi:10.1038/s41588-022-01284-9 · Cited by 136
Self-citationGrowth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis
Kato, E. T., Morrow, D. A., Guo, J., Berg, D. D., Blazing, M. A., Bohula, E. A., Bonaca, M. P., Cannon, C. P., de Lemos, J. A., Giugliano, R. P., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac577 · Cited by 128 · cited 1×
“Recent data suggest GDF15 as an independent prognostic biomarker for individuals with established atherosclerotic cardiovascular disease 32 .”
Choi, B., Lee, S., Kim, S.-M., Lee, E.-J., Lee, S. R., Kim, D.-H., Jang, J. Y., Kang, S.-W., Lee, K.-U., Chang, E.-J., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.024270 · Cited by 117 · cited 1×
“Proteins associated with aortic stenosis demonstrated enrichment for peptidase inhibitor activity, consistent with recent work suggesting an important role for certain peptidases in the progression of calcific aortic stenosis 18 .”
Profibrotic Role for Interleukin-4 in Cardiac Remodeling and Dysfunction
Peng, H., Sarwar, Z., Yang, X.-P., Peterson, E. L., Xu, J., Janic, B., Rhaleb, N., Carretero, O. A., & Rhaleb, N.-E. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05627 · Cited by 111
Genetic analysis of right heart structure and function in 40,000 people
Pirruccello, J. P., Achille, P. D., Nauffal, V., Nekoui, M., Friedman, S. F., Klarqvist, M. D. R., Chaffin, M. D., Weng, L.-C. C., Cunningham, J. W., Khurshid, S. S., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01090-3 · Cited by 106
Self-citationWilliams, S. A., Ostroff, R., Hinterberg, M. A., Coresh, J., Ballantyne, C. M., Matsushita, K., Mueller, C. E., Walter, J., Jonasson, C., Holman, R. R., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abj9625 · Cited by 97 · cited 1×
“For instance, smaller studies have demonstrated that sparse protein-based risk scores can improve the prediction of cardiovascular events in certain populations 7–11 .”
Reproductive Factors and Incidence of Heart Failure Hospitalization in the Women’s Health Initiative
Hall, P. S., Nah, G., Howard, B. V., Lewis, C. E., Allison, M., Sarto, G. E., Waring, M. E., Jacobson, L. T., Manson, J. E., Klein, L., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.557 · Cited by 89
The WAP Four-Disulfide Core Domain Protein HE4: A Novel Biomarker for Heart Failure
de Boer, R. A., Cao, Q., Postmus, D., Damman, K., Voors, A. A., Jaarsma, T., van Veldhuisen, D. J., Dijk, W. A., Hillege, H. L., & Silljé, H. H. W. (2013) · JACC Heart Failure · doi:10.1016/j.jchf.2012.11.005 · Cited by 84 · cited 1×
“Previous research in hospitalized heart failure patients demonstrated associations of circulating WFDC2 with disease severity as well as kidney function 29 .”
Small, A. M., Peloso, G. M., Linefsky, J., Aragam, J., Galloway, A., Tanukonda, V., Wang, L.-C., Yu, Z., Sunitha Selvaraj, M., Farber-Eger, E. H., et al. (2023) · Circulation · doi:10.1161/circulationaha.122.061451 · Cited by 76
Self-citationThe druggable genome and support for target identification and validation in drug developmentPreprint
Finan, C., Gaulton, A., Krüger, F. A., et al. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/066027 · Cited by 73
Ardissino, M., Morley, A., Slob, E. A. W., Schuermans, A., Rayes, B., Raisi‐Estabragh, Z., de Marvao, A., Burgess, S., Rogne, T., Honigberg, M. C., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad631 · Cited by 70 · cited 1×
“…failed, F -statistics were estimated using summary statistics as equation (1): where n indicates the sample size of the original genome-wide association study, k the number of variants included in the genetic instrument and R 2 the variance in the exposure explained by the genetic variants 54 .”
Self-citationProteomic cardiovascular risk assessment in chronic kidney disease
Deo, R., Dubin, R. F., Ren, Y., Murthy, A. C., Wang, J., Zheng, H., Zheng, Z., Feldman, H. I., Shou, H., Coresh, J., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad115 · Cited by 63 · cited 1×
“To minimize the risk of weak instrument bias, we only performed cis -MR analyses for genetic instruments with F -statistics >10.”
Mortensen, M. B., Nordestgaard, B. G., Afzal, S., & Falk, E. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw426 · Cited by 61 · cited 1×
“For instance, most high-risk individuals remain undetected until experiencing their first clinical event 3,4 , and even under currently optimal treatment conditions, there remains substantial residual risk that is incompletely captured by traditional risk factors 5,6 .”
Layilin augments integrin activation to promote antitumor immunity
Mahuron, K. M., Moreau, J. M., Glasgow, J. E., Boda, D. P., Pauli, M. L., Gouirand, V., Panjabi, L., Grewal, R., Luber, J. M., Mathur, A. N., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20192080 · Cited by 59
Autoimmune diseases and new-onset atrial fibrillation: a UK Biobank study
Tilly, M. J., Geurts, S., Zhu, F., Bos, M. M., Ikram, M. A., de Maat, M. P. M., de Groot, N. M. S., & Kavousi, M. (2022) · EP Europace · doi:10.1093/europace/euac244 · Cited by 52 · cited 1×
“As a history of auto-immune diseases represents a risk factor for atrial fibrillation that affects women more strongly than men 40 , it could be possible that the observed sex differences for CD38 reflect a more important role for immunity-related pathways in women.”
Xing, L. Y., Diederichsen, S. Z., Højberg, S., Krieger, D. W., Graff, C., Frikke‐Schmidt, R., OLESEN, M. S., Brandes, A., Køber, L., Haugan, K., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.064361 · Cited by 39 · cited 1×
“…strong associations of circulating NT-proBNP with incident atrial fibrillation 36 and align with recent data from the LOOP trial, suggesting that individuals with elevated NT-proBNP levels may derive more clinical benefit from atrial fibrillation screening than those with lower levels 37 .”
Blood protein levels predict leading incident diseases and mortality in UK BiobankPreprint
Gadd, D. A., Hillary, R. F., Kuncheva, Z., Mangelis, T., Cheng, Y., Dissanayake, M., Admanit, R., Gagnon, J., Lin, T.-C., Ferber, K. L., et al. (2023) · medRxiv · doi:10.1101/2023.05.01.23288879 · Cited by 31
Pathophysiological pathways in patients with heart failure and atrial fibrillation
Santema, B. T., Arita, V. A., Sama, I. E., Kloosterman, M., van den Berg, M. P., Nienhuis, H. L. A., Gelder, I. C. V., van der Meer, P., Zannad, F. M., Metra, M., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab331 · Cited by 16 · cited 1×
“Previous protein-focused analyses in patients with heart failure showed that the presence of atrial fibrillation was associated with activation of amyloid-β-related pathways, with SPON1 as one of the most strongly upregulated proteins in those with atrial fibrillation 28 .”
Genetic Analysis of Right Heart Structure and Function in 40,000 PeoplePreprint
Pirruccello, J. P., Achille, P. D., Nauffal, V. D., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.05.429046 · Cited by 11
Williams, S. A., & Ganz, P. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.add1355 · Cited by 8 · cited 1×
“…cardiovascular prevention (for example, through statins) is offered at progressively lower cardiovascular risk thresholds, it is unlikely that proteomic scores will be an effective standalone test to screen for allocation of primary prevention therapies in people without known risk drivers 33,34 .”
Mika Kivimaki, B., Hingorani, A. D., & Lindbohm, J. V. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abq4810 · Cited by 3 · cited 1×
“…cardiovascular prevention (for example, through statins) is offered at progressively lower cardiovascular risk thresholds, it is unlikely that proteomic scores will be an effective standalone test to screen for allocation of primary prevention therapies in people without known risk drivers 33,34 .”
Cited by
Plasma proteomics links brain and immune system aging with healthspan and longevity
Oh, H. S., Guen, Y. L., Rappoport, N., Urey, D. Y., Farinas, A., Rutledge, J., Channappa, D., Wagner, A. D., Mormino, E. C., Brunet, A., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03798-1 · Cited by 188
A human pan-disease blood atlas of the circulating proteome
Álvez, M. B., Bergström, S., Kenrick, J., Johansson, E., Åberg, M., Akyıldız, M., Altay, Ö., Sköld, H., Antonopoulos, K., Apostolakis, E., et al. (2025) · Science · doi:10.1126/science.adx2678 · Cited by 92
Kasartzian, D.-I., & Tsiampalis, T. (2025) · Life · doi:10.3390/life15010094 · Cited by 74
“Similarly, models incorporating lipidomic and proteomic data extend the predictive scope by offering insights into the molecular mechanisms underlying CVD [34].”
Climente-González, H., Oh, M., Chajewska, U., Hosseini, R., Mukherjee, S., Gan, W., Traylor, M., Hu, S., Fatemifar, G., Ghouse, J., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-00872-0 · Cited by 46
Luo, Y., Zhang, N., Yang, J., Cui, M., Tsoi, K. K., Lip, G. Y. H., Liu, T., & Zhang, Q. (2026) · Nature Communications · doi:10.1038/s41467-026-68956-6 · Cited by 42
“…omics data into linear regression to predict disease risk, which are constrained by assumptions of non-correlation between predictors and linear exposure-outcome associations 16,18 – 20, 23, 25, Our study aims to bridge this gap by proposing a groundbreaking AI-based CardiOmicScore framework.”
Metadata
- Authors
- Schuermans, A., Pournamdari, A. B., Lee, J., Bhukar, R., Ganesh, S., Darosa, N., Small, A. M., Yu, Z., Hornsby, W., Koyama, S., Kooperberg, C., Reiner, A. P., Januzzi, J. L., Honigberg, M. C., & Natarajan, P.
- Affiliations
- Broad Institute (US)
- Fred Hutch Cancer Center (US)
- Harvard University (US)
- Corresponding author
- Honigberg, Michael C.
- Natarajan, Pradeep
- ORCID
- Venue
- Nature Cardiovascular Research
- Published
- 2024-11-21
- Volume
- 3
- Issue
- 12
- Pages
- 1516-1530
- ISSN
- 2731-0590 (ISSN-L)
- PMC
- PMC11634769
- OpenAlex
- W4404595397
- Cited by
- 71
- References
- 75
- Citations by year
- 2026: 36 · 2025: 34 · 2024: 1
- FWCI
- 18.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- Nature Cardiovascular Research (publishedVersion, cc-by-nc-nd)
- medRxiv (acceptedVersion)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion)
- Funders
- Massachusetts General Hospital (Paul & Phyllis Fireman Endowed Chair in Vascular Medicine)
- U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01HL127564, K08HL166687)
- Belgian American Educational Foundation
- American Heart Association (940166, 979465)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Keywords
- circulating proteome, heart disease, coronary artery disease, heart failure, atrial fibrillation, aortic stenosis, SPINT1, sex differences, cardiovascular risk prediction, causal inference, therapeutic target
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.